Immunogenomics is a rising field that combines the study of the immune system and genomics to gain insights into cancer and its treatment. By analyzing the immune contexture and interactions between immune cells and tumor cells, immunogenomics can provide crucial information for therapy response, particularly in immunotherapy. Mutations in BRCA genes, which are well-known for their involvement in breast cancer, can also increase the risk of other types of cancer.
Previous ArticleGlobal Ai In Medical Diagnostics Market To Triple By 2028, Reaching $3.7 Billion With 23.2% Cagr As Revealed In New Report
Next Article Protecting Patient Data In Genai Era